View Older Stories View More Recent Stories
-
Tilray Medical gets Portugal lab approval for in-house cannabis testing
-
iBio reports IBIO-610 muscle-preservation data from primate study
-
Enovix Corporation (ENVX) PT Lowered to $5 at Northland
-
Auranova closes private placement raising $3.68M in shares and units
-
Visara licenses nerve growth factor therapy for rare eye disease
-
Kimberly-Clark secures consents to amend Kenvue notes in exchange offer
-
Scinai signs $5.1M CDMO deal with Nasdaq-listed biopharma
-
Oklo selected for DOE isotope production initiative with Groves 2
-
Rockwell Automation launches CompactLogix 5390 industrial controller
-
IsoEnergy names new VP of exploration, reshuffles geology leadership
-
CoTec Holdings Corp. Notes HyproMag USA Secures Power and Advances Project Readiness for Texas Rare Earth Magnet Recycling and Manufacturing Hub
-
Auranova Announces Closing of Private Placement of Units and Flow-Through Shares
-
Andean Precious Metals Reports Third Quarter 2026 Production and Sales Results
-
The Precision Peptide Company Advances Needle-Free GLP-1 Tirzepatide Patch into Formal U.S. Testing
-
First Majestic Announces Temporary Suspension of NAFTA Arbitration Proceedings as Settlement Framework Agreed to with Mexico
-
Moderna to Report Third Quarter 2026 Financial Results on Friday, November 6, 2026
-
NTG Clarity Extends Framework Agreement with Saudi Customer by Four Years, up to $100M CAD In Additional Work
-
Horizon Space Acquisition I Corp. Announces Definitive Business Combination Agreement with ArcheNova Biotech Corp.
-
Trifecta Gold Secures 100% Interest in Tombstone Gold Belt Projects, Yukon
-
Uniserve Advances Strategic Transformation into Canadian Compute and Digital Infrastructure Platform; Adopts "COMP" Trading Symbol
-
BioHarvest Advances Proprietary Olive Cell Asset to Commercial Readiness, Opening New CDMO Licensing Opportunity
-
INEO Reports 47% Fiscal 2026 Revenue Growth as Q4 Revenue Reaches Record $1.03 Million
-
Kalo Gold Samples 16,361 dU (~16.36 g/t Au est.) at New Kope Road North Occurrence as Wainikoro Heads Toward January Drilling
-
Lavras Gold Defines a District-Scale Gold-in-Soil Corridor at Lavras do Sul and Identifies Cerrito North as a New Exploration Target
-
Strategic Metals Ltd. Announces Acquisition of Control and Direction of Securities of Trifecta Gold Ltd. And Creation of 11 Additional NSR Royalties
-
Avenue Living Selects Elauwit to Deliver Managed WiFi Across 3 U.S. Communities in 3 States
-
Aurania Completes Drilling at Thormodsdalur Gold Project in Iceland
-
Phio Pharmaceuticals Announces Successful Completion of First Commercial-Scale cGMP Batch of PH-762 Drug Substance
-
HyProMag USA Secures Power and Advances Project Readiness for Texas Recycling Magnet Manufacturing Hub
-
Toogood Gold Commences 3,000-Sample Soil Program to Advance District-Scale Gold Targets in Newfoundland
-
Digital Science Research Security Report Finds Short-Term Researcher Ties May Fall Outside U.S. Disclosure Rules
-
NSJ Antimony Corp. (NSJ) (9PZ0) Announces Marketing Agreements
-
Mizuho Downgrades Lantheus Holdings (LNTH) to Neutral
-
Jaguar Uranium releases first resource estimate for Argentina project
-
Wells Fargo beats profit estimates despite revenue miss
-
CoTec Holdings Corp. Notes EU Strategic Project Designation for HyproMag GmbH
-
H.C. Wainwright Reiterates Buy Rating on Envoy Medical (COCH)
-
H.C. Wainwright Reiterates Buy Rating on Palisade Bio Inc. (PALI)
-
H.C. Wainwright Reiterates Buy Rating on Zenas Biopharma (ZBIO)
-
Valor Gold Advances Optimization Program Targeting Updated Courageous Lake Pre-Feasibility Study in Q1 2028
-
H.C. Wainwright Reiterates Buy Rating on Harmony Biosciences Holdings Inc. (HRMY)
-
H.C. Wainwright Reiterates Buy Rating on Halozyme Therapeutics (HALO)
-
H.C. Wainwright Reiterates Buy Rating on Incyte (INCY)
-
Brightstar Lottery signs 5-year Pan Am licensing deal for global games
-
Mizuho Reiterates Outperform Rating on IonQ, Inc. (IONQ)
-
Rosenblatt Reiterates Buy Rating on Meta Platforms Inc. (META)
-
Jefferies Starts Electra (ETRA) at Buy
-
Mizuho Reiterates Outperform Rating on Diamondback Energy (FANG)
-
Enlight Renewable Engergy (ENLT) PT Lowered to $41 at Mizuho
-
Energy Transfer (ET) PT Raised to $26 at Mizuho
